1. Home
  2. FORR vs ASMB Comparison

FORR vs ASMB Comparison

Compare FORR & ASMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FORR
  • ASMB
  • Stock Information
  • Founded
  • FORR 1983
  • ASMB 2005
  • Country
  • FORR United States
  • ASMB United States
  • Employees
  • FORR N/A
  • ASMB N/A
  • Industry
  • FORR Diversified Commercial Services
  • ASMB Biotechnology: Pharmaceutical Preparations
  • Sector
  • FORR Consumer Discretionary
  • ASMB Health Care
  • Exchange
  • FORR Nasdaq
  • ASMB Nasdaq
  • Market Cap
  • FORR 200.2M
  • ASMB 198.6M
  • IPO Year
  • FORR 1996
  • ASMB 2010
  • Fundamental
  • Price
  • FORR $11.21
  • ASMB $22.27
  • Analyst Decision
  • FORR
  • ASMB Strong Buy
  • Analyst Count
  • FORR 0
  • ASMB 4
  • Target Price
  • FORR N/A
  • ASMB $41.33
  • AVG Volume (30 Days)
  • FORR 79.8K
  • ASMB 144.1K
  • Earning Date
  • FORR 11-04-2025
  • ASMB 11-06-2025
  • Dividend Yield
  • FORR N/A
  • ASMB N/A
  • EPS Growth
  • FORR N/A
  • ASMB N/A
  • EPS
  • FORR N/A
  • ASMB N/A
  • Revenue
  • FORR $412,103,000.00
  • ASMB $33,247,000.00
  • Revenue This Year
  • FORR N/A
  • ASMB $11.57
  • Revenue Next Year
  • FORR $1.51
  • ASMB N/A
  • P/E Ratio
  • FORR N/A
  • ASMB N/A
  • Revenue Growth
  • FORR N/A
  • ASMB 54.77
  • 52 Week Low
  • FORR $8.50
  • ASMB $7.75
  • 52 Week High
  • FORR $19.74
  • ASMB $27.17
  • Technical
  • Relative Strength Index (RSI)
  • FORR 72.67
  • ASMB 47.38
  • Support Level
  • FORR $9.76
  • ASMB $20.23
  • Resistance Level
  • FORR $10.69
  • ASMB $22.93
  • Average True Range (ATR)
  • FORR 0.40
  • ASMB 1.26
  • MACD
  • FORR 0.16
  • ASMB -0.49
  • Stochastic Oscillator
  • FORR 83.41
  • ASMB 39.23

About FORR Forrester Research Inc.

Forrester Research Inc provides independent research, data, and advisory services. It operates through the following segments: The Research segment develops and delivers research, connect, and analytics products; The consulting segment includes the revenues and the related costs of the company's consulting organization, and the Events segment is engaged in developing and hosting in-person and virtual events.

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.

Share on Social Networks: